Journal Reviews

Gardasil vaccination for laryngeal RRP – an update

1 October 2018 | | ENTA-Laryngology / Swallowing / Voice | Antibody titers, Gardasil, Laryngeal secretions, Quadrivalent HPV vaccine, Recurrent laryngeal papilloma

This paper reports the results of a follow-up study investigating the possible role of adjuvant Gardasil vaccination in patients with recurrent laryngeal papillomatosis. The preceding study – also published in the Journal of Voice (2017) – reported the changes in...

Gardasil vaccination as an adjuvant treatment for established recurrent laryngeal papillomatosis in male adults - does it stimulate an immune response?

1 May 2017 | | Gardasil, antibody titers, quadrivalent HPV vaccine, ecurrent laryngeal papilloma, recurrent respiratory papillomatosis

Recurrent respiratory papillomatosis (RRP) is well known to be caused by infection with the human papilloma virus (types 6 and 11). Recurrence after surgical removal is common and potentially frequent and severe. Previous research has established that many patients with...

Gardasil vaccination – an effective adjuvant therapy for RRP?

1 May 2015 | | Adjuvant therapy, Gardasil, Quadrivalent HPV vaccine, Recurrent respiratory papilloma, Treatment

The clinical manifestations of recurrent respiratory papillomatosis (RRP) can vary hugely from individual to individual. Whilst some affected children will outgrow the disease, a subset of patients will experience frequent recurrences and require multiple surgical procedures over the course of...